We have more than 10 years of experience in custom synthesis of compounds. If you are looking for a supplier or manufacturer of Alogliptin benzoate (CAS No.: 850649-62-6) please contact us. We can provide customers with custom synthesis from grams to kilograms and the production of tons of compounds. Now, we also hope to meet your needs for Alogliptin benzoate (CAS No.: 850649-62-6) and other compounds. We can provide high-quality compounds and good service fou you.
Name |
Alogliptin benzoate |
Synonyms |
2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]benzonitrile,benzoic acid;SYR 322;Vipidia (TN);alogliptin monobenzoate;Nesina |
Molecular Formula |
C25H27N5O4 |
Molecular Weight |
461.51300 |
CAS Number |
850649-62-6 |
purity |
≥99% |
Availability |
In stock |
Application: Alogliptin (English: Alogliptin), trade name nishina, is a
dipeptidyl peptidase-4 (DPP-4) inhibitor oral anti-diabetes drug, developed by
Takeda Pharmaceutical Industry Co., LTD., Japan in 2005. Like other type 2
diabetes drugs, alagliptin does not increase the risk of heart attack or
stroke. Similar to other lipins, alogliptin causes little weight gain, has a
relatively low risk of hypoglycemia and has moderate hypoglycemic activity.
Alagliptin, like other lipins, is commonly used in combination with metformin
in patients who cannot control blood sugar with metformin alone.